Evaluates markers for differential diagnosis in renal tumors, indicating improved accuracy.
. So, by using combination of four markers (vimentin, CD117, CK7, and Cav-1), we achieved excellent sensitivity and specificity for differential diagnosis of CCRCC, ChRCC and oncocytoma.
No takes yet. Share an insight, caveat, or question.
Alshenawy et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: